Ann Pharmacol Pharm | Volume 7, Issue 1 | Case Report | Open Access

Clinical Case of the Topical Corticosteroid Therapy of the Severe Degree Cow’s Milk Allergy in Infancy

Taranushenko TE^1*, Falaleeva SO^1,2, Makarevskaya NY², Borisova EV², Resnitskiy PA², Ekzarkhov SV², Popov PA² and Shishigina SV³

¹Department of Pediatrics, Institute of Postgraduate Education, Krasnoyarsk State Medical University Named After Prof. Voino-Yasenetsky, Institute of Postgraduate Education for Pediatricians and Neonatologists, Krasnoyarsk, Russia
²Krasnoyarsk Regional Clinical Center for Maternity and Childhood Protection, Krasnoyarsk, Russia
³Krasnoyarsk Regional Pathoanatomical Bureau, Krasnoyarsk, Russia

^*Correspondance to: Taranushenko Tatiana E 

Abstract

Cow's milk allergy is the most prevalent type of food allergy among infants. Taking into account the fact that elimination diet is the main therapeutic point of the food protein-induced enterocolitis syndrome we have demonstrated the clinical case of urgently measures to using glucocorticosteroids in 3-month-old infant.

Keywords:

Food protein-induced enterocolitis syndrome; Cow’s milk allergy; Glucocorticosteroids; Infant

Citation:

Taranushenko TE, Falaleeva SO, Makarevskaya NY, Borisova EV, Resnitskiy PA, Ekzarkhov SV, et al. Clinical Case of the Topical Corticosteroid Therapy of the Severe Degree Cow’s Milk Allergy in Infancy. Ann Pharmacol Pharm. 2022;7(1):1206..